Sommario

• • ·Editorial board

    Pagina :i

    

• Reviews

  • ·SGLT2 inhibition and glucagon secretion in humans

    Pagina :383-385

    C. Saponaro, F. Pattou, C. Bonner

    Riassunto Riassunto Mappa Mappa
  • ·Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies

    Pagina :386-392

    A.J. Scheen

    Riassunto Riassunto Mappa Mappa
  • ·Efficacy and safety of combination therapy with SGLT2 and DPP4 inhibitors in the treatment of type 2 diabetes: A systematic review and meta-analysis

    Pagina :393-401

    Y.K. Cho, Y.M. Kang, S.E. Lee, J. Lee, J.-Y. Park, W.J. Lee, Y.-J. Kim, C.H. Jung

    Riassunto Riassunto Mappa Mappa   

• Original articles

  • ·Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300 U/mL vs glargine 100 U/mL in T2DM

    Pagina :402-409

    R. Roussel, R. Ritzel, E. Boëlle-Le Corfec, B. Balkau, J. Rosenstock

    Riassunto Riassunto Mappa Mappa  
  • ·Risks of diabetic foot syndrome and amputation associated with sodium glucose co-transporter 2 inhibitors: A Meta-analysis of Randomized Controlled Trials

    Pagina :410-414

    D. Li, J. Yufeng Yang, T. Wang, S. Shen, H. Tang

    Riassunto Riassunto Mappa Mappa   
  • ·Relation between HbA_1c and incident cardiovascular disease over a period of 6 years in the Hong Kong population

    Pagina :415-423

    E.Y.F. Wan, E.Y.T. Yu, C.S.C. Fung, W.Y. Chin, D.Y.T. Fong, A.K.C. Chan, C.L.K. Lam

    Riassunto Riassunto Mappa Mappa  
  • ·Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study

    Pagina :424-430

    B.T. Fokkens, R.P. van Waateringe, D.J. Mulder, B.H.R. Wolffenbuttel, A.J. Smit

    Riassunto Riassunto Mappa Mappa   
  • ·Platelet function following induced hypoglycaemia in type 2 diabetes

    Pagina :431-436

    H. Kahal, A. Aburima, B. Spurgeon, K.S. Wraith, A.S. Rigby, T. Sathyapalan, E.S. Kilpatrick, K.M. Naseem, S.L. Atkin

    Riassunto Riassunto Mappa Mappa  
  • ·Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes

    Pagina :437-443

    T.-T. Li, A.-P. Wang, J.-X. Lu, M.-Y. Chen, C.-C. Zhao, Z.-H. Tang, L.-X. Li, W.-P. Jia

    Riassunto Riassunto Mappa Mappa  

• Short report

  • ·Meal-derived glucagon responses are related to lower hepatic phosphate concentrations in obesity and type 2 diabetes

    Pagina :444-448

    K.S. Weber, K. Straßburger, M. Fritsch, A. Bierwagen, C. Koliaki, E. Phielix, G. Pacini, J.-H. Hwang, D.F. Markgraf, V. Burkart, K. Müssig, J. Szendroedi, M. Roden

    Riassunto Riassunto Mappa Mappa   

• Research letters

  • ·Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up

    Pagina :449-451

    V. Ponzo, L. Gentile, R. Gambino, R. Rosato, I. Cioffi, N. Pellegrini, A. Benso, F. Broglio, M. Cassader, S. Bo

    Mappa Mappa
  • ·Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

    Pagina :452-455

    J.-Y. Lee, Y. Cho, M. Lee, Y.-H. Lee, B.-W. Lee, E.S. Kang, B.-S. Cha

    Mappa Mappa